Prophylactic salpingo‐oophorectomy in a series of 89 women carrying a <i>BRCA1</i> or a <i>BRCA2</i> mutation

Abstract

This study shows that prophylactic SO remains an important option for BRCA1/2 mutation carriers as asymptomatic ovarian/fallopian cancers were found in 4.5% of patients. However, a longer follow-up and larger series are required to more precisely evaluate the benefits of this procedure in terms of BC incidence, peritoneal malignancy, or recurrence.